Skip to main content
. Author manuscript; available in PMC: 2015 Jul 8.
Published in final edited form as: Science. 2015 Feb 26;347(6227):1253–1256. doi: 10.1126/science.aaa0672

Fig. 3. CRMP ameliorates liver disease in a rat model of NASH.

Fig. 3

(A) Liver triglyceride content. (B and C) Plasma ALTand AST. (D) Liver inflammatory cytokine concentrations, normalized to total protein. n = 4 rats per group. (E) Liver histology. Scale bars, 100 μm. (F) Fibrosis score. (G) Liver collagen mRNA. (H) Liver smooth muscle actin protein. (I) Hepatic hydroxyproline content. (J and K) Liver caspase 3 and caspase 9 protein. (L) Plasma albumin. Unless otherwise specified, n = 6 to 8 rats per group. Data are mean ± SEM, with comparisons by means of analysis of variance.